SmeNSEPeers Name Company ProfileUPCOMING
Kheria Autocomp IPO
₹96 – ₹96 · Issue Size ₹46.44 CrIPO Overview
Business Model
Competitive Advantages
- Experience-Driven Manufacturing Excellence
- Our Company, incorporated in 2009 has developed over a decade of operational experience in the field of plastic injection
- Over the years, we have established and maintained business relationships with several Tier‑I automotive component suppliers.
- These customers, in turn, cater to OEMs in the passenger vehicle segment, including both electric and internal combustion engine
IPO Timeline
Strengths & Weaknesses
Strengths
- Experience-Driven Manufacturing Excellence
- Our Company, incorporated in 2009 has developed over a decade of operational experience in the field of plastic injection
- Over the years, we have established and maintained business relationships with several Tier‑I automotive component suppliers.
- These customers, in turn, cater to OEMs in the passenger vehicle segment, including both electric and internal combustion engine
Management & Promoters
V
Vinay KheriaManaging Director
T
Tara Chand KheriaDirector and Chairman
S
Sushma KheriaDirector
S
Santosh Devi KheriaDirector
A
Ankur AgarwalIndependent Director
P
Paarasha-Nirman LLPIndependent Director
M
Mittal Nirman LLPIndependent Director
N
Nilesh Jashvantbhai BhagatIndependent Director
P
Priya Lavkush SomaniIndependent Director
D
Devi KheriaDirector
Peer Comparison
| Company | P/E | EPS |
|---|---|---|
| Kheria Autocomp IPO | — | — |
| Dated: September | 30.0x | — |
| Please read Section and of the Companies Act | 26.0x | — |
| Website: www.kheria.com E-Mail: [email protected]; Telephone No | 91.0x | — |
Pre-IPO Financials
| Period | Revenue (Cr) | PAT (Cr) | Net Worth (Cr) | Total Assets (Cr) |
|---|---|---|---|---|
| March 2025 | ₹20 Cr | — | ₹4.5 Cr | — |
| March 2024 | ₹16.7 Cr | — | ₹4.5 Cr | — |
| March 2023 | ₹92.31 Cr | — | ₹28.24 Cr | — |
| 2025 | ₹62.4 Cr | — | ₹20 Cr | — |
| 2024 | ₹50.24 Cr | — | ₹16.7 Cr | — |
About
Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica
| Exchange | NSE |
| Issue Type | sme |
| Sector | Peers Name Company Profile |
| Face Value | ₹10 per share |
Documents
rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.